the teats prior to suckling, has been largely elucidated on the and 3 MRC Reproductive Biology Unit, 37 Chalmers Street, basis of studies in certain animal models: namely the pig, the Edinburgh, Scotland, UK rat and the guinea pig (reviewed in Sherwood, 1994). In these 4 To whom correspondence should be addressed species there is a large increase in circulating relaxin in the third trimester of pregnancy, to reach hormone concentrations The pattern of peripheral serum concentration for the at least 10-fold higher than the known dissociation constant peptide hormone relaxin in women points to the possibility (K d ) of the relaxin receptor. In the human and anthropoid of an interesting paracrine function in the cycle and early primates this is not the case: maximal circulating concentrations pregnancy. In order to investigate this physiology in detail, of relaxin are found in the first trimester of pregnancy and it was decided to examine local relaxin biosynthesis in an they barely exceed 1-2 ng/ml (Eddie et al., 1986 ; Steinetz established primate model for human female reproductive et al., 1992), which is below the 0.44 nM (~3 ng/ml) K d function, the marmoset monkey (Callithrix jacchus). In this reported for binding of the hormone to its receptor (Osheroff initial study relaxin biosynthesis was assessed using a and King, 1995). However, concentrations as low as 0.03 nM combination of molecular and immunological techniques have been shown to be effective in cell culture (Cronin et al., through the oestrous cycle in the marmoset monkey. Sortino et al., 1989) . This would suggest that, at least nucleotide sequence of the full-length relaxin gene tranin the human and other primates, a systemic relaxin physiology script was cloned from the marmoset ovary and found to in the perinatal phase, as in other species, is unlikely; serum be closely homologous to that of the human H2 relaxin.
species there is a large increase in circulating relaxin in the third trimester of pregnancy, to reach hormone concentrations The pattern of peripheral serum concentration for the at least 10-fold higher than the known dissociation constant peptide hormone relaxin in women points to the possibility (K d ) of the relaxin receptor. In the human and anthropoid of an interesting paracrine function in the cycle and early primates this is not the case: maximal circulating concentrations pregnancy. In order to investigate this physiology in detail, of relaxin are found in the first trimester of pregnancy and it was decided to examine local relaxin biosynthesis in an they barely exceed 1-2 ng/ml (Eddie et al., 1986 ; Steinetz established primate model for human female reproductive et al., 1992) , which is below the 0.44 nM (~3 ng/ml) K d function, the marmoset monkey (Callithrix jacchus). In this reported for binding of the hormone to its receptor (Osheroff initial study relaxin biosynthesis was assessed using a and King, 1995). However, concentrations as low as 0.03 nM combination of molecular and immunological techniques have been shown to be effective in cell culture (Cronin et al. , through the oestrous cycle in the marmoset monkey. The 1987; Sortino et al., 1989) . This would suggest that, at least nucleotide sequence of the full-length relaxin gene tranin the human and other primates, a systemic relaxin physiology script was cloned from the marmoset ovary and found to in the perinatal phase, as in other species, is unlikely; serum be closely homologous to that of the human H2 relaxin.
relaxin concentrations are more likely to reflect local paracrine Using gene specific probes derived from this sequence, functions which predominate in early pregnancy, possibly in RNase protection assays, reverse transcription-polymerase relation to implantation. Support for a role in implantation is chain reaction (RT-PCR) assays and in-situ hybridization, provided by Stewart et al. (1993) , who showed significantly showed relaxin gene expression within the ovary in theca increased concentrations of relaxin in women undergoing cells and corpora lutea in the oestrous cycle, increasing in spontaneous early abortion. Relaxin-like immunoreactivity has early pregnancy. Relaxin gene expression was also identified been detected by immunoassay in the uterus, ovary and at a low level in the uterus and placenta, and at a higher cervix of non-pregnant women (Bongers-Binder et al., 1991) . level in the prostate in the male marmoset monkey. Using Additionally, relaxin has been shown in vitro to be a major two different relaxin-specific antisera, relaxin-like immunostimulator of cAMP in endometrial cells from the human nonreactivity was observed in the ovary with a pattern of pregnant uterus (Fei et al., 1990) , and is evidently involved in distribution coincident with that obtained by in-situ hybridthe decidualization of endometrial stromal cells (Zhu et al., ization . Immunoreactivity was also found in the non-1990; Bell et al., 1991; Tabanelli et al., 1992) . pregnant uterus, within the endometrial epithelium of the Little is known about the expression of relaxin or its function late proliferative phase and increasing within the glands in either the non-pregnant or pregnant cycles, or in early through the secretory phase. Taken together, the pattern pregnancy, especially in primates. In order to examine such a of relaxin peptide and mRNA expression show there is the physiology we have first assessed the biosynthesis of relaxin basis for local relaxin physiology within the ovarian follicle at both mRNA and protein levels in the female reproductive and corpus luteum, and within the uterus during thedemonstrated to have circulating relaxin-like immunoreactivity . Local biosynthesis of relaxin was demonstrated using a combination of mRNA techniques employing species-specific cloned relaxin cDNA probes, as well as immunohistochemistry using two different antisera to indicate the precise cellular distribution of the hormone.
Materials and methods

Animals and tissues
Adult female marmoset monkeys (Callithrix jacchus) from a captive breeding colony at the German Primate Center in Göttingen, Germany, were housed in pairs under controlled environmental conditions, and cycle status was monitored by twice weekly assessment of plasma progesterone concentrations (Einspanier et al., 1994) . The length of the oestrous cycle in the marmoset is 28 days, ovulation normally occurring around day 10. In certain experiments animals were synchronized by application of a luteolytic dose of prostaglandin F 2α on day 12 of the luteal phase (Einspanier et al., 1994) . For nonconceptive cycles, females were housed with castrated males. Tissues were removed from 14 animals under anaesthesia as described previously (Einspanier et al., 1994) . Ovaries and uteri were collected from seven different stages: early (n ϭ 2) or late [before endogenous luteinizing hormone (LH) increase, n ϭ 2; after exogenous HCG application, n ϭ 2] follicular phase, early (day 3-4 after ovulation; n ϭ 2), mid-(day 8-9 after ovulation; n ϭ 2) and late (day 12-13 after ovulation; n ϭ 2) luteal phase (equivalent to days 17-18, days 21-22, and days 26-27 of the luteal phase respectively, in the human), as well as early pregnancy (Ͻ40 days, n ϭ 2). Placental tissue was obtained immediately following a spontaneous or assisted birth respectively. Prostate tissue was obtained from a sexually mature male culled as part of a management programme. Tissues from each animal were separately portioned, one part being frozen immediately in liquid nitrogen and stored until use at -80°C, and one part immersion-fixed for immunohistochemistry in phosphate-buffered 4% paraformaldehyde for 4 h at 4°C, prior to paraffin-embedding (see below). For the preparation of the cDNA library, ovaries were collected from two adult female marmosets from the colony at the MRC Reproductive Biology Unit in Edinburgh. These animals were in the follicular phase of the non-pregnant cycle.
RNA preparation and analysis RNA was prepared from frozen tissue fragments according to the method of Chomczynski and Sacchi (1987) . In order to obtain a species-specific cDNA fragment, reverse transcription-polymerase chain reaction (RT-PCR) was performed as previously described (Hartung et al., 1995) , using oligonucleotide primer combinations Figure 1 . Nucleotide sequence of the full-length cDNA and corresponding to conserved regions of the relaxin precursor sequence deduced amino acid sequence of the marmoset relaxin precursor (Hartung et al., 1995) . The resulting~440 bp PCR fragment was polypeptide. The amino acid sequence is shown as a comparison subcloned into the plasmid pCRII (Invitrogen, San Diego, CA, USA) with the human H2 relaxin sequence with which it bears close homology. Asterisks indicate amino acid identity. The putative and sequenced.
receptor binding domain within the B-domain is boxed. An RNase protection assay was established with the help of a commercial kit (Ambion, Austin, TX, USA). For the probe, a 271 bp DNA fragment was generated from the marmoset relaxin-cDNA inserted PCR sequence, included 87 nucleotides of vector sequence. As control for the integrity of the RNA a second RNase protection (see below) by RT-PCR using as forward and reverse primers oligonucleotides from positions 260-279 and 512-531 (see Figure 1) assay was established for the marmoset glyceraldehyde 3-phosphate dehydrogenase (GAPDH) enzyme. A 197 bp PCR product was respectively. This PCR product was cloned into the pGEM-T vector (Promega, Madison, WI, USA) and the sequence checked by direct obtained from a longer cloned cDNA fragment of the marmoset GAPDH-cDNA (Einspanier and Ivell, 1997) , using for the PCR double-stranded sequencing. This plasmid was linearized with NcoI and transcribed in the presence of [α 32 P]-CTP (Amersham-Buchler, reactions the oligonucleotides 5Ј-GTCTTCACCACCATGGAG-3Ј (forward primer) and 5Ј-ATGGATGACCTTGGC-3Ј (reverse primer). Braunschweig, Germany) using SP6 RNA polymerase (Stratagene, La Jolla, CA, USA) to provide a cRNA probe which, in addition to the This PCR product was cloned into the pCRII vector (Invitrogen). Samples: C ϭ water negative control; 1, uterus, proliferative (day 4 follicle) phase; 2, uterus, proliferative (day 4 follicle) phase; 3, uterus, proliferative (day 4 follicle) phase; 4, uterus, secretory (day 14 luteal) phase; 5, uterus, secretory (day 12 luteal) phase; 6, uterus, secretory (day 9 luteal) phase; 7, uterus, proliferative (day 7 follicle) phase; 8, uterus, secretory (day 9/10 luteal) phase; 9, CL day 5 luteal phase; 10, CL day 5 luteal phase; 11, CL day 8/9 luteal phase; 12, CL day 8/9 luteal phase; 13, CL early pregnancy (~2 months); 14, CL early pregnancy (~2 months); 15, CL mid-pregnancy (~3 months); 16, prostate.
The plasmid was linearized with HindIII and transcribed using T7 derived from the cloned full-length cDNA sequence (forward primer: nucleotides 131-149; reverse primer: nucleotides 512-531; see RNA polymerase (Stratagene) to provide a cRNA probe of 323 bp, which additionally included 126 bp of vector sequence. RNase Figure 1 ). This assay yields a PCR product of 400 bp. Total RNA (2 µg) was used as template in a standard 50 µl reverse transcription protection assays were evaluated by electrophoresis on 6.5% polyacrylamide sequencing gels followed by autoradiography.
reaction. 1 µl of the resultant single-strand (ss)-cDNA was then used as template for the PCR reaction which included a touch-down Since in some tissue samples the specific RLX-mRNA was either very low or undetectable using the RNase protection assay, a specific annealing temperature of 55-45°C, an elongation temperature of 72°C and a denaturing step at 95°C. All steps were for 1 min each, and RT-PCR assay was established using new oligonucleotide primers following 30 cycles the reaction products were elongated for 10 min antibody solution. Two different rabbit polyclonal anti-porcine relaxin antibodies were used (serum 258; Sherwood and Rutherford, 1981 ; at 72°C. The PCR products were analysed by 1.2% agarose gel electrophoresis followed by transfer to Hybond Nϩ (Amershamand R6; O'Bryne and Steinetz, 1976 ; courtesy of Dr O.David Sherwood, University of Illinois, and Dr Bernard Steinetz, New York Buchler, Braunschweig, Germany) membranes and hybridization with an internal relaxin-specific probe. This probe was derived by PCR University Medical Center respectively), diluted 1:1000 for ovarian sections and 1:2000 for uterine sections. A rabbit polyclonal 3β-HSD using the cloned relaxin cDNA (Figure 1 ) as template and as primers the oligonucleotides 193-211 (forward primer) and 372-391 (reverse antibody (S683; Keeney et al., 1993 ; courtesy Professor Ian Mason, University of Edinburgh) was used at a dilution of 1:500, and a mouse primer). This 198 bp PCR product was labelled with [α 32 P]-dCTP (Amersham-Buchler) by random primer labelling and the hybridizing monoclonal anti-progesterone receptor (PR; Affinity Bioreagents Inc, Golden, CO, USA) was diluted 1:50 before use. All antibody dilutions DNA bands visualized by conventional autoradiography. As control for the quality of the ss-cDNA prepared, parallel PCR reactions were were in PBS. Immunological epitopes were detected using avidinbiotin-peroxidase (ABC) and PAP visualization techniques, as performed using oligonucleotide primers specific for the marmoset GAPDH gene sequence as described previously (Einspanier and described previously (Einspanier and Ivell, 1997) . Some sections were additionally counterstained with haematoxylin, as indicated in Ivell, 1997). After transfer of the electrophoresed products to nylon membranes (Hybond Nϩ), these were visualized by hybridization to the figure legends. For the detection of both progesterone receptor and relaxin in the an internal 25mer oligonucleotide (5Ј-CCTTCGATGCTGGGGCTG-GCATTGC) radiolabelled by T4 polynucleotidyl kinase (New Engsame sections, the following double-staining technique was used. After rehydration in a descending series of ethanol, sections were land Biolabs, Schwalbach, Germany) in the presence of [γ 32 P]-ATP (Amersham-Buchler).
incubated in 10 mM citrate buffer, pH 6.0, at 120°C for 10 min, followed by cooling for 30 min to room temperature. Sections were Molecular cloning of the marmoset relaxin cDNA then rinsed in PBS, incubated in 0.0125% trypsin (Gibco-BRL, Glasgow, UK) at 37°C, then rinsed again in PBS. Slides were then In order to obtain a cDNA sequence corresponding to the complete treated with 3% H 2 O 2 in a humidified chamber for 20 min, rinsed relaxin gene transcript of the marmoset ovary, and hence also the again and then incubated with 1:10 diluted mouse IgG (Dianova) for full-length encoded amino acid sequence of the relaxin precursor 30 min, followed by an overnight incubation at 4°C with the first polypeptide, a cDNA library was constructed using the lambda primary antibody, against the progesterone receptor, also at a dilution bacteriophage vector Uni-Zap-XR (Stratagene) from mRNA derived of 1:10 in PBS. After further rinsing in PBS, biotinylated anti-mouse from four ovaries from two non-pregnant adult female marmosets, IgG (Vector Laboratories, Burlingame, MA, USA) was applied at a exactly as described elsewhere for marmoset testis (Saunders et al., dilution of 1:300 for 30 min. After rinsing in PBS, sections were 1996). The library, which had an estimated complexity of 2ϫ10 5 incubated in a humidified chamber for 40 min at 4°C in the ABC independent clones and an average insert size of 870 bp (range 300-complex reagent (10 µl avidin, 10 µl biotinylated horseradish peroxid-2000 bp), was screened using the original~440 bp relaxin-specific ase in 1 ml PBS; Vector Laboratories), followed after further brief PCR product (see above). Two independent clones were selected and rinsing in PBS by DAB/nickel incubation in a humified chamber in cDNA isolated by phagemid rescue followed by conventional cDNA the dark at room temperature for 8 min. Following this step, the preparation procedures (Sambrook et al., 1989) . The nucleotide sections were washed successively in water and PBS each for 5 min sequence of the two clones was obtained in both orientations by the before incubating in normal rabbit serum (diluted 1:100 in PBS) in conventional dideoxynucleotide termination protocol for doublea humidified chamber for 15 min. After draining off the serum, the stranded DNA.
second primary antibody, anti-porcine relaxin, diluted 1:500 in PBS, was then applied to the sections for 1 h in a humidified chamber.
In situ hybridization
Sections were then washed twice in PBS and the secondary antibody In-situ hybridization was performed on 10 µm cryofixed sections of (biotinylated anti-rabbit IgG; Vector Laboratories) applied. This was frozen marmoset ovaries from the various cycle stages as indicated, followed by a 40 min incubation in ABC complex reagent (see above) using [α 35 S]-CTP-labelled cRNA probes as previously described by at room temperature. Sections were then again washed twice in Ivell et al. (1990) . The antisense and sense cRNA probes were PBS before applying the second chromogen substrate, AEC (Vector transcribed from the 441 bp PCR fragment which is specific for Laboratories) for 15 min. The sections were then washed for 5 min marmoset relaxin and had been cloned into the pCRII vector (see in water before mounting in Mowiol (Hoechst, Frankfurt, Germany). above). For antisense probes the vector was linearized with NotI and incubated with SP6 RNA polymerase; for the sense probes used as negative control the same vector was linearized with HindIII and incubated with T7 RNA polymerase.
Results
Cloning and sequence analysis of marmoset relaxin Immunohistochemistry
Immunohistochemistry was carried out on 3 µm paraffin sections Using a combination of oligonucleotide primers shown to mounted on 0.01% poly-L-lysine (Sigma, Deisenhofen, Germany)-exhibit high homology between the relaxin molecules already coated slides. Sections were dried for 1 h at 45°C, dewaxed in xylol described from various species, a 441 bp PCR fragment was for 6 min, followed by descending ethanols, and then rinsed in isolated using luteal RNA from early pregnancy as template phosphate-buffered saline (PBS; Instamed Dulbecco's without Ca 2ϩ (Hartung et al., 1995) . This was subcloned, sequenced and and Mg 2ϩ , and made up at 9.55 g/l to pH 7.5; Biochrom, Berlin, used as a probe to isolate full-length clones from a cDNA determined by complete sequencing of two independent fullafter longer autoradiographic exposure (not shown). Granulosa cells were negative, as were the uterine samples. Because the length clones, encoded the complete relaxin precursor polypeptide of 185 amino acids from the marmoset. This polypeptide GAPDH controls of the illustrated uterine samples suggested only low concentrations of mRNA, six further uterine samples conformed to the common A-B-C domain structure of all the relaxin molecules so far described, and includes a classic from independent animals, three from the luteal phase and three from the follicular phase were additionally analysed. In signal peptide at the N-terminus, with which the molecule is directed to the secretory pathway. The probable signal peptidase spite of strong GAPDH-mRNA signals, all six tissues remained negative for relaxin-mRNA (not shown). Of other tissues cleavage site, following the rules of Von Heijne (1986), is at Ala 24 . The marmoset prorelaxin shows greatest homology to tested, the prostate (lane18) was positive, but liver and pituitary, used as negative controls, were not. Because of the very the human H2 prorelaxin (71%) with the homology being equally distributed through A-, B-and C-domains. Possible limited amounts of RNA available it was not possible to perform GAPDH controls on all samples. Thus for samples 5, cleavage sites within the precursor to form an A-B heterodimer are indicated in Figure 1 based on the human homology, though 7, and 10-12, this assessment of RNA integrity was not performed. However, small aliquots of all RNA samples were whether the marmoset prorelaxin is indeed cleaved must await further studies.
checked prior to all analyses by gel electrophoresis to verify the quantity and quality especially of the 18S and 28S ribosomal The full-length cDNA sequence predicts a mRNA of~0.9 kb, allowing~150 residues for the polyadenylate tail. This is RNA (not shown). According to these criteria all RNA samples appeared to be intact and equivalent amounts were used for similar to what has been observed in Northern hybridization of human luteal RNA . Unfortunately, it was the subsequent assays. not possible to extract marmoset tissues to obtain sufficient Reverse transcription-polymerase chain reaction RNA for northern hybridization. However, tissue samples were analysed using an RNase protection assay (see below) which RT-PCR assays were established for relaxin and GAPDH using species-specific oligonucleotide primers. RT-PCR assays confirmed the homology in the region of the subcloned and protected probe.
are much more sensitive than either Northern hybridization or RNase protection assays, and were therefore used especially RNase protection analysis to detect possible low level expression of relaxin gene transcripts in those tissue samples which had proved negative in Because of the small amounts of RNA which could be extracted from marmoset tissues, specific relaxin-mRNA concentrations the less sensitive assays. All the samples which were positive in the RNase protection were assessed using an RNase protection assay (Figure 2) . RNase protection assays, by depending upon the protection assay gave strong positive signals in the RT-PCR analysis (Figure 3) . Additionally, weak positive signals were now from RNase A digestion by duplex formation of a singlestranded cRNA probe with a mRNA molecule, are absolutely obtained for most of the luteal RNA samples from the non-pregnant cycle (Figure 3, lanes 9-12) . Furthermore, on stoichiometric and provide a reliable quantitative estimate of specific mRNA concentrations in a given tissue. The presence prolonged autoradiographic exposure of the Southern blotted PCR products, weak positive signals could now be obtained of relaxin-mRNA in a sample gave rise to a protected band at the expected 271 b (Figure 2) . The appearance of a doublet at for all of the uterine samples ( Figure 3, lanes 1-8) . Unfortunately, there was insufficient RNA from the granulosa and this position is probably due to a single base heterogeneity in the cloned probe construct. The tissues with the highest levels theca cell preparations to perform RT-PCR on these samples. of expression were the corpus luteum and stromal tissue In-situ hybridization (including luteal islets and some preantral follicles, but excluding corpora lutea) from ovaries of early to mid-pregnancy
The 441 bp RT-PCR product (Hartung et al., 1995) was subcloned into the pBS plasmid and after linearization with (Figure 2, lanes 5-9) , and in the male, the prostate (Figure 2 , lane 18). Even after long exposure, no specific signals were either HindIII or NotI used to direct in-vitro transcription using either T7 (sense) or SP6 (antisense) RNA polymerase detectable from luteal RNA of the non-pregnant cycle (lanes 1-4). Additionally, RNA from theca cells (lane 12), and from respectively, in the presence of [α-35 S]-CTP. The resulting cRNA probes were then used to detect relaxin gene transcripts placental tissue (lane 15) showed a positive signal. Although in Figure 2 only the sample of placental RNA from the by in-situ hybridization to cryostat sections of marmoset ovaries at various stages of the oestrous cycle (Figure 4) . spontaneous birth provides a visible signal, a weaker positive signal is also evident for the placenta of the induced birth Specific signals (white silver grains) are already evident in the (Sherwood and Rutherford, 1981) . (H) Preovulatory follicle exactly as in (G), but using the R6 anti-relaxin antibody (O'Byrne and Steinetz, 1976) . Immunostaining is localized within the cytoplasm; nuclei are counterstained with haematoxylin (original magnification ϫ375).
theca cell layer of preovulatory follicles ( Figure 4A ). This a third potentially steroidogenic tissue component capable of producing relaxin. specific signal persists after ovulation with the formation of
The physiological role of relaxin in the cycle and early the corpus luteum. The luteal signal is relatively weak in the pregnancy is unclear, but has been linked to implantation of early luteal phase ( Figure 4C ) of the oestrous cycle, but the blastocyst and endometrial function. Additionally, in some increases in intensity through the mid ( Figure 4E ) to late species, there is evidence to suggest a local production of ( Figure 4G ) luteal phases. Control sections hybridized with relaxin within the uterus. In order to characterize the presence the sense cRNA probe (Figures 4I-P) , indicated no significant of relaxin in the marmoset uterus, tissue sections were analysed differences in signal intensity from background levels. In immunohistochemically through the follicular and luteal phases addition to the specific signals illustrated in Figure 4 , relaxin of the cycle and in pregnancy. In the non-pregnant cycle, there transcripts were also sporadically detected within the stromal is staining for relaxin-like epitopes in the epithelial cells during tissue of the ovary, in small islands of luteal-like cells (luteal the proliferative phase ( Figure 7B ). This staining increases in islets; see later).
the secretory phase ( Figure 7C ), where there is in addition staining in some stromal cells. Maximal staining is seen in the Immunohistochemical detection of relaxin-like epitopes glandular epithelium during the late secretory phase. It should Expression of the relaxin peptide was assessed immunohistobe noted that in the early to mid-proliferative phase, the chemically using two different polyclonal antibodies raised staining for relaxin is not homogeneous in all epithelial cells, against porcine relaxin, and shown to cross-react with relaxin some cells being heavily stained, others showing no staining from several species. Within the ovary, relaxin epitopes were ( Figure 7B ). During pregnancy, there is enhanced staining in detected using both antibodies within the theca cell layer of the deep stromal cells ( Figure 7F ), though the epithelial cells antral and preovulatory follicles and within corpora lutea. In in this region are negative. Closer to the luminal surface of the follicular phase there is an increase in staining intensity in the uterus ( Figure 7G ) there is an increase in immunoreactive the theca cells, which attains a maximum following the artificial staining not only in the stromal cells, but also now in the gonadotrophin surge ( Figure 5F ,G). Similar intensity of epithelial cells of the glands. All decidual cells ( Figure 7H ) immunostaining is obtained irrespective of which polyclonal stain strongly for relaxin immunoreactivity. anti-relaxin antibody is used ( Figure 5G,H) . Granulosa cells remain negative throughout the cycle. Once formed the corpus luteum shows steadily increasing relaxin immunoreactivity Discussion through the luteal phase ( Figure 5B-D) , though there is a Like a number of other mammalian groups, the female marmodecline in intensity on approaching luteal regression set exhibits the expression of a relaxin gene within tissues of ( Figure 5D ). Note that not all luteal cells are positive. Highest the reproductive tract. As in most species, the corpus luteum signal intensity is observed in corpora lutea of early pregnancy of pregnancy appears to produce the highest concentrations of ( Figure 5E ), followed by mid luteal phase, then early or late this hormone. This probably accounts for the maximum levels luteal phase. In preliminary double-labelling experiments, it of relaxin immunoreactivity detected for this species in pericould be shown that some but not all of the relaxin-positive pheral serum in mid pregnancy by Steinetz et al. (1995) . luteal cells also stained for 3β-HSD and PR (not shown), Indeed, in women becoming pregnant after ovarian stimulation though there did not appear to be a clear-cut correlation of the the serum concentrations of relaxin appear to reflect the number epitopes in terms of either distribution or intensity of staining.
of follicles ovulating, and hence the number of resulting Stromal cells were consistently negative for relaxin immunocorpora lutea (Kristiansson et al., 1996) . In the present study reactivity.
there is good agreement between the in-situ hybridization In addition to the follicles and corpora lutea, small islands data, the RT-PCR and RNase protection assessment of RNA of luteal-like cells are apparent within the stroma, which concentrations and the immunohistochemical findings, all conalso react positively to the relaxin antisera ( Figure 6E-G) , sistently showing the corpus luteum and the theca cells of the throughout the entire follicular and early/mid-luteal phases. preovulatory follicle to be major sites of relaxin biosynthesis, Nearly all of the luteal-like cells in these clusters stain and equally validating the reliability of the antibodies to detect positively for relaxin epitopes. These luteal islets also show true relaxin epitopes. marked in-situ hybridization to the relaxin-specific cRNA Although highest levels of relaxin expression are evident probes ( Figure 6B) , showing that there is true relaxin biosynin pregnancy, there nevertheless appears to be significant thesis in these ectopic structures. A subsequent, more detailed expression also in the non-pregnant cycle, within both the immunohistochemical analysis indicates that these luteal islets theca cells and the corpus luteum. This pattern of expression are also positive for steroidogenic components, such as 3β-is similar to that reported also for the pig (Fields and Fields, HSD (not shown) and the progesterone receptor ( Figure 6D ).
1985; Bagnell et al., 1987 Bagnell et al., , 1990a , and human (Ivell et al., Whereas the majority of the luteal-like cells also stain for 3β-1989; Stoelk et al., 1991) . It has been suggested that relaxin HSD, only about half stain for PR. Thus in double-labelling may be involved in the rat in stimulating the production by experiments ( Figures 6F,G) luteal-like cells are evident which granulosa cells of collagen metabolizing enzymes, such as tPA stain positively for both relaxin and PR (arrows), and some (Too et al., 1984) , and hence having a role in tissue remodelling, for relaxin only. Taken together, it would appear that the possibly associated with ovulation and formation of the corpus luteum (Hwang et al., 1996) . Relaxin also appears to influence marmoset ovary contains besides the corpora lutea and follicles DNA synthesis by granulosa cells (Zhang and Bagnell, 1993) .
species, such as the human (Gagliardi et al., 1992) . Here, synthesis only appears to occur once these cells have luteinized The finding of relaxin biosynthesis in vivo within the theca cells and luteal cells of the cycle, but not in granulosa cells, in vitro, and thus might be comparable to the relaxin-positive cells of the corpus luteum in vivo, although whether such luteal could nevertheless be consistent with the observations of relaxin biosynthesis in cultured granulosa cells from other cells are of theca or granulosa cell origin, or both, is not clear. An exciting finding from the present study was the relaxin immunoreactivity in the endometrium of early pregnancy, especially in those regions close to the sites of presence of so-called luteal islets within the stromal tissue of the ovary and discrete from luteal and follicular structures.
implantation, but not, for example, in the mesometrial endometrium or in the non-conceptus-bearing uterus. Relaxin The cells comprising these islets exhibit nuclear progesterone receptor immunoreactivity as well as the 3β-HSD enzyme, also appears to influence myometrial contractility, acting, for example, in the rat non-pregnant uterus to dampen and can thus be considered as true, albeit ectopic luteal cells. That these cells also express high concentrations of oxytocin-or endothelin-induced contractions (Goldsmith et al., 1989; McGovern et al., 1992) as well as reducing relaxin mRNA and peptide suggests that they are served by similar regulatory mechanisms as the other steroidogenic spontaneous contractions in a number of species (Downing and Hollingsworth, 1993) . tissues of the ovary at this time. Whether these luteal islets also contribute to the circulating concentrations of relaxin Systemic relaxin in the late cycle and early pregnancy of the primate, including the human (Eddie et al., 1986 ; Stewart is not known, though their mass relative to that of the corpus luteum would suggest the latter still to be the major et al., 1990; Johnson et al., 1993) , chimpanzee , rhesus macaque (Stewart et al., 1993 ; Duffy source of serum relaxin. The source of these luteal islets is obscure; they might be stromal in origin, or derive from et al., 1995) and marmoset never exceeds~2 ng/ml, i.e lower than the determined K d for the existing corpora lutea, or alternatively be remnants of luteinized but non-ovulated follicles. Morphologically, howrat relaxin receptor (Osheroff and King, 1995) . In agreement with this, relaxin only influences porcine granulosa cells or ever, they would appear to be different from the pseudodecidual cells described for the pregnant human ovary by human endometrial stromal cells at concentrations 1Ͻ10 ng/ ml, with a half-maximal response at 4-5 ng/ml (Fei et al., Blankenship et al. (1994) .
Specific relaxin-mRNA in total uterine extracts is undetect-1990; Zhang and Bagnell, 1993) , though anterior pituitary cells can respond to as little as 0.2 ng/ml (Cronin et al., able using the RNase protection assay, but can be detected at low values by RT-PCR. Using two different antibodies, 1987). Thus, serum relaxin concentrations in primates during the cycle and in early pregnancy may not in themselves be immunohistochemistry indicates clear positive signals in endometrial tissues of both the cycle and pregnancy. Relaxin physiologically relevant, but rather reflect local biosynthesis within the ovary and uterus. Local concentrations within would appear to be present in both stromal as well as epithelial cells, though especially the latter indicate significant the follicle, corpus luteum and uterus are likely to be much higher, and thus certainly able to activate the relaxin relaxin immunoreactivity first in the late secretory phase and especially in the decidua. Thus it would appear that, receptors which have been shown for several species to be in the immediate neighbourhood of these relaxin sources. as in other species such as the rabbit (Lee and Fields, 1990) , pig (Knox et al., 1994) human (Bryant-Greenwood Specific relaxin-mRNA signals were also detected in the term placenta and the prostate gland, showing that the et al., 1993) and guinea pig (Larkin and Renegar, 1986) , relaxin can be produced locally within the endometrium, marmoset conforms closely with the tissue-specific pattern of gene expression demonstrated for the human. Also in particularly in the secretory phase of the cycle and in pregnancy.
the human, maximal concentrations are expressed in the corpus luteum, followed in order of magnitude by the There are few data discussing a function for relaxin in the uterus of the menstrual cycle. The most significant of placenta, and prostate. Although a new world monkey, and thus not closely related to the anthropoid primates, the these is the observation that relaxin appears to be an important stimulator of cAMP (Fei et al., 1990) and together marmoset thus appears to present a suitable model with which to assess the role of relaxin in the physiology of the with progesterone can induce decidualization in in-vitro cultures of human endometrial stromal cells from the cycle female primate, especially during the cycle and periimplantation period. The cloning of the specific marmoset (Zhu et al., 1990; Bell et al., 1991; Tabanelli et al., 1992; Lane et al., 1994) . Taken together these findings would imply transcript for relaxin allows not only the development of such sequence specific assays as in-situ hybridization and an important role for ovarian relaxin in the differentiation of the endometrium at the end of the cycle. In vivo, this is the RNase protection assay, but also offers the opportunity to produce biotechnologically a bioactive marmoset relaxin an essential prerequisite for implantation. It is interesting to note that both in the rat (Fields et al., 1992) and the rabbit by expression in appropriate cell systems. The development of such tools would then allow optimal use of the (Fields and Lee, 1991), there appears to be expression of Figure 7 . Immunohistochemistry for relaxin in the non-pregnant (A-C) and early pregnant (E-G) uterus, and in decidua (D, H) of the marmoset monkey. Panels A, D and E are negative controls where the primary antibody was replaced by an equivalent amount of immunoglobulin (Ig)G. Panels A-C show non-pregnant uterus from the proliferative (B) and secretory (A, C) phases, indicating weak or strong immunostaining, respectively, in the glandular epithelial cells. Panels E and F represent early pregnant uterus, showing deep glands staining specifically only in stromal cells (F), but in more luminal areas (G) there is strong immunostaining in both stromal and epithelial cells. Panels D and H shows a section of the decidua from an early pregnant uterus, with specific staining in nearly all cells. All illustrated sections made use of anti-relaxin 258 (Sherwood and Rutherford, 1981) . The R6 antibody gave similar results (not shown). Positive immunostaining for relaxin in these paraformaldehyde-fixed and paraffin-embedded sections is represented by a red colour. Sections are counterstained for cell nuclei using haematoxylin (original magnifications: A-C and E-G, ϫ375; D and H, ϫ625).
